Persistent diabetic macular edema: Definition, incidence, biomarkers, and treatment methods
-
Published:2023-03
Issue:2
Volume:68
Page:147-174
-
ISSN:0039-6257
-
Container-title:Survey of Ophthalmology
-
language:en
-
Short-container-title:Survey of Ophthalmology
Author:
Sorour Osama A.ORCID,
Levine Emily S.,
Baumal Caroline R.,
Elnahry Ayman G.ORCID,
Braun Phillip,
Girgis Jessica,
Waheed Nadia K.
Reference209 articles.
1. OE Adams, SA Schechet and SM. Hariprasad, Discontinuous to continuous therapy for persistent diabetic macular edema leads to reduction in treatment frequency, Eur J Ophthalmol, 31(2), 2021, 612-619, Available from http://www.ncbi.nlm.nih.gov/pubmed/31964171.
2. Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial;Ahmadieh;Br J Ophthalmol,2019
3. Effects of subthreshold diode micropulse laser photocoagulation on treating patients with refractory diabetic macular edema;Akhlaghi;J Curr Ophthalmol,2019
4. Choroidal thickness after dexamethasone implant or aflibercept in patients with diabetic macular edema persistent to ranibizumab;Aksoy;J Ocular Pharmacol Ther,2020
5. What is chronic or persistent diabetic macular edema and how should it be treated?;Apte;JAMA Ophthalmol,2016
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献